Similar articles for PMID: 11794990

Year	Number of Results
1970	1
1977	1
1996	1
2001	1
2002	3
2003	4
2004	3
2005	6
2006	5
2007	5
2008	4
2009	5
2010	1
2011	1
2012	2
2014	1
2015	2
2017	1
2024	0

1

[Simvastatin attenuates cardiovascular effects and oxidative stress induced by angiotensin II].

Delbosc S, Cristol JP, Mimran A, Jover B. Delbosc S, et al. Arch Mal Coeur Vaiss. 2001 Nov;94(11):1199-202. Arch Mal Coeur Vaiss. 2001. PMID: 11794990 French.

2

Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.

Rugale C, Delbosc S, Mimran A, Jover B. Rugale C, et al. J Cardiovasc Pharmacol. 2007 Sep;50(3):293-8. doi: 10.1097/FJC.0b013e3180a72606. J Cardiovasc Pharmacol. 2007. PMID: 17878758

3

Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.

Bayorh MA, Ganafa AA, Eatman D, Walton M, Feuerstein GZ. Bayorh MA, et al. Am J Hypertens. 2005 Nov;18(11):1496-502. doi: 10.1016/j.amjhyper.2005.05.022. Am J Hypertens. 2005. PMID: 16280288

4

The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.

Coccia R, Spadaccio C, Foppoli C, Perluigi M, Covino E, Lusini M, Chello M. Coccia R, et al. Clin Ther. 2007 Aug;29(8):1706-17. doi: 10.1016/j.clinthera.2007.08.010. Clin Ther. 2007. PMID: 17919551 Clinical Trial.

5

Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets.

Pech V, Sikka SC, Sindhu RK, Vaziri ND, Majid DS. Pech V, et al. Am J Hypertens. 2006 May;19(5):534-40. doi: 10.1016/j.amjhyper.2005.11.008. Am J Hypertens. 2006. PMID: 16647629

6

Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.

Delbosc S, Cristol JP, Descomps B, Mimran A, Jover B. Delbosc S, et al. Hypertension. 2002 Aug;40(2):142-7. doi: 10.1161/01.hyp.0000024348.87637.6f. Hypertension. 2002. PMID: 12154104

7

Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.

Whaley-Connell A, Govindarajan G, Habibi J, Hayden MR, Cooper SA, Wei Y, Ma L, Qazi M, Link D, Karuparthi PR, Stump C, Ferrario C, Sowers JR. Whaley-Connell A, et al. Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E355-63. doi: 10.1152/ajpendo.00632.2006. Epub 2007 Apr 17. Am J Physiol Endocrinol Metab. 2007. PMID: 17440033 Free article.

8

Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.

Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Malý J, Kramer HJ, Dvorák P, Cervenka L. Kopkan L, et al. Vascul Pharmacol. 2009 Aug-Sep;51(2-3):175-81. doi: 10.1016/j.vph.2009.06.001. Epub 2009 Jun 16. Vascul Pharmacol. 2009. PMID: 19539780

9

Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.

Neves MF, Amiri F, Virdis A, Diep QN, Schiffrin EL; CIHR Multidisciplinary Research Group on Hypertension. Neves MF, et al. Can J Physiol Pharmacol. 2005 Nov;83(11):999-1006. doi: 10.1139/y05-068. Can J Physiol Pharmacol. 2005. PMID: 16391708

10

Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.

Yagi S, Aihara K, Ikeda Y, Sumitomo Y, Yoshida S, Ise T, Iwase T, Ishikawa K, Azuma H, Akaike M, Matsumoto T. Yagi S, et al. Circ Res. 2008 Jan 4;102(1):68-76. doi: 10.1161/CIRCRESAHA.107.163493. Epub 2007 Oct 25. Circ Res. 2008. PMID: 17967781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

41 results

Results by year